181 related articles for article (PubMed ID: 23044365)
1. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
[TBL] [Abstract][Full Text] [Related]
2. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A; Schmeil I; Karn T; Becker S; Sänger N; Holtrich U; Arsenic R
Pathol Oncol Res; 2018 Apr; 24(2):277-282. PubMed ID: 28470574
[TBL] [Abstract][Full Text] [Related]
3. MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
Ma FH; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
J Magn Reson Imaging; 2014 Sep; 40(3):745-51. PubMed ID: 24395397
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of epidemiological factors between serous and mucinous borderline ovarian tumors: therapeutic implications].
Fauvet R; Demblocque É; Morice P; Querleu D; Gondry J; Daraï É
Bull Cancer; 2012 May; 99(5):551-6. PubMed ID: 22510207
[TBL] [Abstract][Full Text] [Related]
5. MRI appearances of borderline ovarian tumours.
Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging findings of mucinous borderline ovarian tumors: comparison of intestinal and endocervical subtypes.
Woo S; Kim SH; Kim MA; Park IA; Lee MS; Kim SY; Cho JY
Abdom Imaging; 2015 Aug; 40(6):1753-60. PubMed ID: 25504376
[TBL] [Abstract][Full Text] [Related]
7. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
8. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
Benito V; Lubrano A; Arencibia O; Medina N; Álvarez Eva E; Andújar M; Falcón Juan M; Falcón O
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):188-92. PubMed ID: 20728981
[TBL] [Abstract][Full Text] [Related]
9. MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Wang SJ; Qiu HY; Wang L
J Magn Reson Imaging; 2014 Jan; 39(1):162-6. PubMed ID: 24123278
[TBL] [Abstract][Full Text] [Related]
10. Characteristic features of ovarian borderline tumors with invasive implant.
Ohta T; Ohmichi M; Hayasaka T; Saitoh M; Kojimahara T; Kawagoe J; Nakahara K; Motoyama T; Kurachi H
Arch Gynecol Obstet; 2005 Oct; 272(4):278-82. PubMed ID: 16012777
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
[TBL] [Abstract][Full Text] [Related]
12. Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor.
Qian XQ; Hua XP; Wu JH; Shen YM; Cheng XD; Wan XY
Int J Gynecol Cancer; 2018 Feb; 28(2):279-284. PubMed ID: 29194193
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
14. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
[TBL] [Abstract][Full Text] [Related]
15. [Borderline ovarian tumors].
Ivanov S
Akush Ginekol (Sofiia); 2002; 42(1):23-5. PubMed ID: 11935694
[TBL] [Abstract][Full Text] [Related]
16. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
17. MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
Naqvi J; Nagaraju E; Ahmad S
Clin Radiol; 2015 Apr; 70(4):424-32. PubMed ID: 25515794
[TBL] [Abstract][Full Text] [Related]
18. Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics.
Ye F; Hu Y; Lu W; Zhou C; Xie X
Histopathology; 2008 Aug; 53(2):224-8. PubMed ID: 18540977
[No Abstract] [Full Text] [Related]
19. [Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma].
Jin S; Zhang W; Wang H; Liu Y; Gao F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Dec; 21(6):455-9. PubMed ID: 12567493
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging.
Chen M; Wang WC; Zhou C; Zhou NN; Cai K; Yang ZH; Zhao WF; Li SY; Li GZ
Chin Med Sci J; 2006 Dec; 21(4):270-5. PubMed ID: 17249204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
